drugset / Trial / NCT02771743
Response-based Treatment of High-risk Neuroblastoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to improve outcome of high risk neuroblastoma by tailoring the treatment intensity of tandem high dose chemotherapy according to the treatment response to induction chemotherapy.
Timeline
- Start
- 2015-04
- Primary completion
- 2020-03
- Completion
- 2023-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Ifosfamide | Small molecule | — | — |
| Subject | Isotretinoin | Other / unclassified | — | — |
| Subject | aldesleukin | Protein / enzyme biologic | — | — |